Analyst Coverage
Argus Research
|
Martha Freitag
|
Bank of America Merrill Lynch
|
Rachel McMinn
|
Barclays Capital
|
Jim Birchenough
|
Bernstein Research
|
Geoffrey Porges
|
BDR Research Group
|
Matt Duffy & Matt Jacobson
|
Collins Stewart
|
Salveen Kochnover
|
Cowen & Company
|
Phil Nadeau
|
Credit Suisse
|
Michael Aberman
|
Deutsche Bank
|
Mark Schoenebaum
|
FTN Equity Capital Markets
|
Biren Amin
|
Goldman Sachs
|
Davis Bu
|
Jefferies & Co.
|
Eun Yang
|
JP Morgan Chase
|
Geoffrey Meacham
|
Lazard Capital Markets
|
Bill Tanner
|
Leerink Swann
|
Joshua Schimmer
|
Morgan Joseph & Co.
|
Shiv Kapoor
|
Morgan Stanley
|
Steven Harr
|
Oppenheimer & Co.
|
Brian Abrahams
|
RBC Capital Markets
|
Michael Yee
|
Robert W. Baird
|
Chris J. Raymond
|
Smith Barney Citigroup
|
Yaron Werber
|
Standard & Poor’s
|
Frank DiLorenzo
|
Summer Street Research Partners
|
Jon Stephenson
|
Thomas Weisel Partners
|
Stephen Willey
|
UBS Research
|
Maged Shenouda
|
Wells Fargo
|
Aaron Reames
|
William Blair
|
John Sonnier
|
The analysts listed follow Genzyme Corporation. We are providing this list as a service and not as an endorsement or adoption of the information provided by these analysts. Any opinions or estimates regarding the performance of Genzyme made by these analysts are theirs and do not represent the opinions of Genzyme. We are not responsible for information provided in analyst reports, including inaccuracies they may contain. Some of the analysts firms may be market-makers in Genzyme's stock and/or hold other long or short positions in the stock, and may provide services to Genzyme for which they are compensated.
|
|
|
|
CONTACT INFORMATION: |
|
Genzyme Investor Relations
500 Kendall Street
Cambridge, MA 02142
T: 617 252 7500
Patrick Flanigan – 617 768 6563
Investor Information Line
U.S. T: 800 905 4369
Outside the U.S. T: 678 999 4572
Shareholder Contact
For questions about your shares, replacement of a lost stock certificate or a change of address call our transfer agent.
American Stock Transfer
59 Maiden Lane
New York, NY 10038
T: 212 936 5100
or
Genzyme Shareholder Services
T: 617 768 6686
|
|
|
|
Home
